Established in **1992** and listed on the **BSE** since **1993**, Ajanta Soya Limited (**ASL**) is a prominent Indian manufacturer and marketer of Vanaspati, Refined Edible Oils, and specialized Bakery Shortening. Headquartered in **Delhi** with primary manufacturing operations in **Rajasthan**, the company has evolved from a regional player into a key supplier for India’s leading FMCG giants while simultaneously building a robust portfolio of consumer brands. --- ### **Core Product Portfolio & Brand Architecture** ASL operates through a single integrated business segment: **Vanaspati and Refined Oil**. The company’s strategy balances high-volume institutional sales with high-margin branded retail products. * **Edible Oils & Fats:** A comprehensive range including Refined **Palm, Soyabean, Groundnut, Mustard, and Cottonseed** oils. * **Vanaspati & Bakery Specializations:** Specialized fats designed for the food processing industry, specifically for **biscuits, puffs, and pastries**. * **Brand Strategy:** Approximately **50%** of total revenue is generated through ASL’s proprietary brands. * **Key Brands:** *Dhruv, Anchal, Parv, ASL, ASL Pure, ASL Fine Fingers,* and *Nutri 1992*. * **Institutional Footprint:** ASL is a critical ingredient partner to India’s premier food manufacturers, including: * **Britannia Industries Ltd** * **Parle Biscuits Ltd** * **ITC Ltd** * **Surya Food & Agro Ltd** * **Parsons Nutritionals Pvt Ltd** --- ### **Manufacturing Infrastructure & Operational Scale** The company’s operations are centralized at a high-efficiency, **ISO 22000:2005** certified facility designed for low-cost production and rigorous quality control. * **Location:** SP-916, RIICO Industrial Area, Phase III, Bhiwadi, Distt. Alwar, Rajasthan. * **Installed Capacity:** **1,65,000 MTPA**. * **Production Volume:** ASL produced **97,353.85 MT** of Vanaspati/Refined Oil in FY24, with volumes remaining steady at **94,977.47 MT** in the subsequent period. * **R&D Focus:** In-house research teams focus on optimizing manufacturing costs and developing "affordable innovation" to meet the shifting health preferences of Indian consumers. --- ### **Financial Performance & Recovery Trajectory** Following a challenging FY23 marked by inventory losses, ASL demonstrated a significant recovery in **Fiscal 2025**, characterized by **30% year-on-year revenue growth** and a sharp rebound in profitability. #### **Comparative Financial Summary** | Metric | Unit | FY 2025 (Est./Prov.) | FY 2024 | FY 2023 | | :--- | :--- | :--- | :--- | :--- | | **Total Income** | Rs. Crore | **1,338.49** | **1,031.31** | **1,236.20** | | **Profit After Tax (PAT)** | Rs. Crore | **27.15** | **4.03** | **~1.00** | | **Operating Margin** | % | **2.8% - 3.0%** | **0.75%** | **0.50%** | | **Net Worth** | Rs. Crore | **150 - 160** | **130** | **125.8** | | **Interest Coverage** | Times | **8.0 - 9.0** | **1.77** | **2.13** | | **Adj. Debt/Networth** | Times | **< 0.1** | **0** | **0.01** | *Note: FY25 growth was driven by an **11% volumetric increase** and improved palm oil realizations.* --- ### **Capital Structure & Credit Profile** ASL maintains a conservative balance sheet with **negligible gearing** and high liquidity. * **Credit Ratings (as of June/July 2025):** * **Long-Term:** **CRISIL BBB-/Positive** (Outlook recently upgraded from Stable). * **Short-Term:** **CRISIL A3** (Reaffirmed). * **Liquidity Position:** Rated as **Adequate**. As of May 2025, the company held **Rs 58 crore** in marketable securities and **Rs 10-11 crore** in cash equivalents. * **Banking Facilities:** Total rated bank loan facilities of **Rs. 170 Crore** remain largely unutilized, providing significant headroom for expansion. * **Working Capital Management:** Efficient cycle with **Gross Current Assets (GCA)** maintained between **45-55 days**. --- ### **Strategic Growth Drivers & Market Outlook** ASL is positioning itself to capture the "consumption gap" in India’s edible oil market through several strategic levers: * **Health-Conscious Pivot:** Developing heart-friendly oils (Rice Bran, Canola, Sunflower) to address rising lifestyle diseases. * **Demographic Tailwinds:** Targeting the rising young urban population, projected to reach **36% of India's total by FY 2036**. * **Rural Penetration:** Expanding beyond traditional distribution into **rural haats** and modern digital retail formats. * **Digitization:** Leveraging digital platforms for targeted consumer communication, bypassing traditional legacy distribution bottlenecks. --- ### **Governance, Leadership & Promoter Commitment** The company has recently undergone a leadership strengthening and seen increased equity commitment from its founders. * **Promoter Activity:** Between September 2025 and March 2026, the **CKG Family Trust** and promoter group acquired **5,91,450 equity shares** from the open market. **Mrs. Chander Kala Goyal** currently holds **36.59%** of the equity. * **Key Leadership:** * **Mr. Sushil Kumar Goyal (MD):** Re-appointed through July 2026. * **Mr. Arun Tyagi (WTD):** Appointed in January 2024 to strengthen operational oversight. * **Mr. Rupesh Deorah (Independent Director):** Appointed in April 2024, bringing **28+ years** of M&A and Corporate Finance expertise. * **Non-Core Strategic Assets:** ASL holds equity investments in **Dhruv Globals Limited** (**Rs. 674.07 Lakhs**), **DG Estates** (**Rs. 163.65 Lakhs**), and **Ajanta Realtech** (**Rs. 113.85 Lakhs**). --- ### **Risk Matrix & Mitigation Strategies** ASL operates in a high-volatility environment, managed through a formal **Risk Management Policy** and an internal audit department. | Risk Category | Impact & Context | Mitigation Strategy | | :--- | :--- | :--- | | **Commodity Volatility** | High sensitivity to **Crude Palm Oil (CPO)** and Mustard seed prices. | Focus on increasing plant throughput and capacity utilization to protect margins. | | **Import Dependency** | Exposure to **Indonesia’s B40 mandate** and geopolitical shifts in the Black Sea. | Diversified sourcing and monitoring of global trade flows. | | **Foreign Exchange** | Significant USD trade payables (**Rs 74.12 Cr** in FY23). | Hedging **60-70%** of requirements via forward contracts; no speculative trading. | | **Regulatory Risk** | Import duty hikes (e.g., **Sept 2024** increase to **27.5% - 35.75%**). | Dynamic pricing models to pass through duty fluctuations to consumers. | | **Credit Risk** | Trade receivables rose to **Rs 34.80 Cr** in March 2025. | Strict 21-day credit terms and security deposits for high-risk accounts. | | **Legal/Compliance** | Recent notices from **Customs (Ahmedabad)** and **GST Authorities**. | Active legal management and internal compliance audits. |